» Articles » PMID: 35212768

Effects of Ranibizumab and Zoledronic Acid on Endometriosis in a Rat Model

Overview
Date 2022 Feb 25
PMID 35212768
Authors
Affiliations
Soon will be listed here.
References
1.
Sourial S, Tempest N, Hapangama D . Theories on the pathogenesis of endometriosis. Int J Reprod Med. 2015; 2014:179515. PMC: 4334056. DOI: 10.1155/2014/179515. View

2.
Zhou W, Yang H, Shao J, Mei J, Chang K, Zhu R . Anti-inflammatory cytokines in endometriosis. Cell Mol Life Sci. 2019; 76(11):2111-2132. PMC: 11105498. DOI: 10.1007/s00018-019-03056-x. View

3.
Onalan G, Tohma Y, Zeyneloglu H . Effect of Etanercept on the Success of Assisted Reproductive Technology in Patients with Endometrioma. Gynecol Obstet Invest. 2017; 83(4):358-364. DOI: 10.1159/000484895. View

4.
Dull A, Moga M, Dimienescu O, Sechel G, Burtea V, Anastasiu C . Therapeutic Approaches of Resveratrol on Endometriosis via Anti-Inflammatory and Anti-Angiogenic Pathways. Molecules. 2019; 24(4). PMC: 6413140. DOI: 10.3390/molecules24040667. View

5.
Rosenfeld P, Brown D, Heier J, Boyer D, Kaiser P, Chung C . Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006; 355(14):1419-31. DOI: 10.1056/NEJMoa054481. View